Novo Nordisk Foundation gives 736m euro grant to Denmark’s BioInnovation Institute
The funding will run until 2035 and will help the organisation to expand its presence in Europe
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Moderna and Merck announce data from melanoma combination therapy study
Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths
Lilly announces acquisition of Ventyx Biosciences for around $1.2bn
Multiple Ventyx drugs are currently in phase 2 development for inflammatory disease
Novartis’ ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease
Approximately half of those with Sjögren’s disease are thought to be undiagnosed
AbbVie reaches agreement for affordable prescription drugs with US government
The pharma company has also pledged a $100bn investment in US infrastructure over the next decade
Novo Nordisk Foundation gives 736m euro grant to Denmark’s BioInnovation Institute
The funding will run until 2035 and will help the organisation to expand its presence in Europe
Latest content
Vibrant Therapeutics appoints Han Lee as co-CEO
Lee previously held senior roles at ImmPACT Bio, Neogene Therapeutics and AstraZeneca
Read More
NanoSyrinx appoints Thomas J Farrell as CEO
Farrell was previously founder and CEO of two NASDAQ-listed companies
Read More
VML Health appoints Nadine Leonard as Global Chief Solutions & Innovation Officer
Leonard was previously Therapeutic Area Lead for Pfizer’s oncology branch
Read More
Enhanced Genomics appoints Katerina Leftheris to Board of Directors
Leftheris has held senior scientific roles at Bristol Myers Squibb and Celgene
Read More
Intelligence
The trust crisis: how pharma must evolve to engage Gen Z HCPs
Trust isn’t a campaign outcome; it’s the product of behaviour, language and consistency
Read More
Setting out – why omnichannel success is about orchestration
Today’s audiences listen simultaneously to multiple channels, from social media to digital detailing, which leak into each other like a commuter’s headphones on a crowded train
Read More
Global regulatory standards
The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial readiness
Read More
Patient insight: human vs AIHCPS
If we’re using AI to inform healthcare decisions, ethical guard rails are essential
Read More
Bridging the affordability gap
How pharma can rebuild competitiveness from the factory floor
Read More
ESMO 2025 – ensuring innovation isn’t lost in translation
This year marks the congress’s 50th anniversary, with the theme: Many journeys. One global community
Read More
Blogs
Latest
First impressions matter: Why getting your onboarding right is key for digital engagement
January 20, 2026 | Graphite Digital|Digital engagement in healthcare, HCP onboarding, Healthcare digital transformation, Pharmaceutical digital platforms
As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs …
How will AI change field training?
January 15, 2026 | Inizio|Generative AI, Intelligent Commercialization
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force …
The Heart and Mouth Connection Every Woman Needs to Know
January 9, 2026 | Medscape Education|Women in Leadership, Women in healthcare, podcast
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria …
Inizio Ignite Sparks a New Era of Connected Advisory Solutions
January 7, 2026 | Inizio|Inizio Ignite
Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance …
MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke
January 7, 2026 | Inizio|Intelligent Commercialization
The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who …
How can pharma build genuine partnerships with patient communities?
January 19, 2026 | Amiculum|patient advocacy, patient engagement
Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines …
Five Predictions That Will Reshape Biopharma Commercialisation in 2026
January 5, 2026 | Nmblr|
Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A …
What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends
December 16, 2025 | Amiculum|AI, JCA, Market Access, Patient-integrated Communications, VuuAI, genAI, healthcare communications, misinformation, omnichannel, trends
By Sarah Theobald
Clinical research in 2026: The trends shaping tomorrow
December 16, 2025 | Cuttsy + Cuttsy|Communications, Decentralised trials, Digital, Pharma, advocacy, clinical trials, partnerships, patient engagement
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
AI persona generation for healthcare: quick wins & real-world impact
December 4, 2025 | Amiculum|AI, Persona generation, Segmentation, artificial intelligence, healthcare communications, omnichannel
By Aaron Fletcher